*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Analysts at ShoreCap reiterated their 'buy' recommendation on shares of AstraZeneca following news that Brussels had approved its Qtrilmet treatment for controlling blood sugar levels in patients suffering from Type-2 diabetes.
Analysts at Cannacord Genuity cut their target price on shares of Weir Group to reflect to reflect a now more sombre outlook for only a "modest recovery over an extended period" in the company's oil and gas operations.
Peel Hunt upgraded its stance on shares of Capital & Counties to 'buy' from 'add' on Thursday, lifting the price target to 300p from 280p as it pointed to "significant upside" from a double disposal.
Analysts at Canaccord Genuity lowered their rating on Tullow Oil from 'buy' to 'speculative buy' on Thursday following a disappointing trading update from the firm in the previous session.
Analysts at Berenberg lowered their target price on shares of British construction firm Taylor Wimpey slightly, from 200. 0p to 190. 0p, noting that the better volumes seen year-to-date appeared to have come at the expense of margins.
Analysts at JP Morgan reiterated their 'overweight' stance on shares of Coca-Cola Hellenic Bottling despite the bottler's recent 'miss' on third quarter volumes.
Peel Hunt upgraded its stance on shares of Capital & Counties to 'buy' from 'add' on Thursday, lifting the price target to 300p from 280p as it pointed to "significant upside" from a double disposal.
Analysts at Barclays reiterated NMC Health (overweight; target price: 4,275. 0p) as their 'top pick' within the sector following a roadshow by the company's management earlier in the same week.
Analysts at Berenberg downgraded aerospace and defence firm Senior from 'buy' to 'hold' on Tuesday, saying that the group's wings had been "clipped" after its management lowered their growth outlook.
Analysts at Liberum hiked their target price for shares of Howden Joinery, telling clients that investors were likely to continue pursuing "quality cyclicals" if the increasing demand for UK assets was sustained.
Analysts at JP Morgan reiterated their 'overweight' recommendation and 2,450. 0p target price for shares of Ashtead ahead of the group's second quarter update on 10 November.
Analysts at Berenberg downgraded aerospace and defence firm Senior from 'buy' to 'hold' on Tuesday, saying that the group's wings had been "clipped" after its management lowered their growth outlook.
Analysts at Berenberg lowered their price target on British sub-prime lender Provident Financial on Monday despite stating that the group appeared to be "firmly on the road to recovery".
Aston Martin Lagonda got a boost on Monday as HSBC upped its stance on the stock to 'buy' from 'hold' and lifted the price target to 550p from 533p, saying the launch of the DBX could be a turning point for the equity story.
Aston Martin Lagonda got a boost on Monday as HSBC upped its stance on the stock to 'buy' from 'hold' and lifted the price target to 550p from 533p, saying the launch of the DBX could be a turning point for the equity story.
